Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage

John Keeling1, Guillermo A Herrera

  • 1Department of Pathology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130, USA.

Kidney International
|September 17, 2005
PubMed
Abstract

Insights

Matrix metalloproteinases (MMPs) are significantly more expressed in AL-amyloidosis (AL-Am) than light chain deposition disease (LCDD), highlighting their role in kidney disease pathogenesis.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • Matrix metalloproteinases (MMPs) are zinc endopeptidases crucial for extracellular matrix (ECM) remodeling.
  • Mesangial ECM alterations are central to the pathogenesis of AL-amyloidosis (AL-Am) and light chain deposition disease (LCDD).

Purpose of the Study:

  • To investigate and compare the expression patterns of five specific MMPs (MMP-1, 2, 3, 7, and 9) in AL-Am and LCDD.
  • To elucidate the role of MMPs in the distinct pathogenetic mechanisms of these two glomerular diseases.

Main Methods:

  • Analysis of MMP protein expression in renal tissues and cultured human mesangial cells (HMCs) treated with patient-derived light chains.
  • Determination of MMP mRNA expression in microdissected glomeruli using microarray.
  • Assessment of MMP activity via zymography.

Main Results:

  • Glomerular MMP expression was significantly higher (6-fold) in AL-Am compared to LCDD and controls.
  • AL-Am tissues and HMCs treated with light chains showed elevated MMP mRNA and protein levels.
  • Zymography revealed increased MMP-2 activity specifically in AL-Am.

Conclusions:

  • Altered matrix metalloproteinase expression is a key factor in the pathogenesis of AL-Am and LCDD.
  • MMP expression levels are markedly higher in AL-Am than in LCDD, suggesting differential roles in disease progression.